CD8A and neoplasm: Additionally, impaired degradation of branched-chain amino acids (BCAAs) in 2 C-type serine/threonine protein phosphatase (PP2Cm)-deficient mice has been found to result in BCAA accumulation in CD8+ T-cells, which enhanced anti-tumor immunity [127].